echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nat Med: In vitro reconstruction of human blood-brain barrier and study of APOE4 pathogenic mechanism

    Nat Med: In vitro reconstruction of human blood-brain barrier and study of APOE4 pathogenic mechanism

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    In Alzheimer's disease, amyloid protein deposits along brain blood vessels lead to a condition called brain amyloid vascular disease (CAA), which impairs the function of the blood-brain barrier (BBB) and accelerates cognitive degradationStudies have shown that lipoprotein 4 (APOE4) is the strongest risk factor for CAA, but the mechanism of this genetic susceptibility is not clearRecently, researchers developed a 3D model based on induced pluripotent stem cells, which reproduces the anatomical and physiological properties of human BBB in vitroSimilar to CAA, in this in vitro BBB model, significantly more amyloid protein accumulation was shown in APOE4 than in APOE3Combined experiments showed that the calcium protein-nucleic factor (NFAT) signal that activates T cells and the misalignment of APOE in surrounding cell-like wall cells induce APOE4-related CAA pathologyIn the human brain, APOE and NFAT are selectively misaligned in the surrounding cells of APOE4 carriersIn vitro and in vivo, inhibiting the transduction of calcium urea-NFAT signals can reduce the occurrence of APOE4-related CAA pathologyAs a result, the study revealed the role of cell circumference cells in APOE4-mediated CAA and highlighted the calcium nerve element-NFAT signal as a therapeutic target for CAA and Alzheimer's disease
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.